Part 3 of the GIP series, cardiac benefits of GIP and a deep dive of the remarkable SURPASS CVOT trial results
Less nausea, more insulin sensitivity, and a little less inflammation Part 2 in a series on GIP
The master incretin of the alpha and beta cell starts to shinePart 1 in a series on GIP
